Gene BioTech
Gene BioTech (진바이오텍) is a South Korean fermentation biotech company founded in 2000 that develops and sells proprietary microbial feed additives, animal pharmaceuticals (via Daonechem), and functional ingredients (via US subsidiary Nutraferma) to livestock producers and animal nutrition companies across 15+ countries.
- Company typePublic
- Founded2000
- HeadquartersGongju, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Gene BioTech does
Gene BioTech (진바이오텍) is a South Korea-based fermentation-focused life sciences company founded in 2000, specializing in animal feed additives, agricultural bioproducts, and animal pharmaceuticals. The company operates three primary revenue streams: proprietary feed additive sales (Artvill, PepSoyGen, Natufermen, Enervance, D-L Methionine), animal pharmaceuticals through wholly-owned subsidiary Daonechem (주)다원케미칼, established 1969, and global functional ingredient distribution through US-based Nutraferma Inc., established in 2007. Underlying technology is built on solid-state fermentation methods combined with proprietary microbial strain engineering, leveraging Korean traditional fermentation techniques alongside modern biotechnology. The company has developed a portfolio of proprietary microbial strains including Bacillus lentimorbus GB-102, Aspergillus oryzae GB-106, Bacillus subtilis GR-101, Lactobacillus acidophilus GB-LC2, and Bacillus licheniformis GB-F2, protected by 35-38+ patents spanning feed additives, mycotoxin degradation, histamine decomposition, and methane reduction.
The business model is B2B sales-led, serving commercial livestock producers (pig, poultry, ruminant, aquaculture) and animal nutrition companies globally, with products distributed direct to enterprise customers and exported to 15 countries through Daonechem and Nutraferma. Manufacturing infrastructure includes Factory 1 in Gongju-si (Chungcheongnam-do headquarters), Factory 2 in Siheung-si (Gyeonggi-do), and Nutraferma's US facility with 10,000+ tons annual capacity. Gene BioTech is a KOSDAQ-listed entity (despite small headcount of 11-50) filing regular DART disclosures, with cumulative $6.8M in R&D funding over the past decade from Korean government agencies including IPET and multiple universities.
The go-to-market centers on direct enterprise sales backed by sustained R&D collaboration with at least five Korean universities (Seoul National, Dankook, Kyungpook, Chungnam, Sunchon National) and continued patent output (most recent filing September 2025 for ruminant methane-reduction additives). Strategic positioning targets antibiotic-free animal production, feed efficiency improvement, and environmental sustainability — addressing regulatory pressure to reduce antibiotic use in livestock and emerging carbon-reduction requirements in ruminant agriculture. Revenue concentration appears distributed across general livestock-producer and animal-nutrition segments, with no named end-customer logos disclosed in available data.
Gene BioTech firmographics
Firmographics- Name
- Gene BioTech
- Legal name
- (주)진바이오텍
- Website
- https://genebiotech.co.kr
- Company type
- Public
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gene BioTech (진바이오텍) is a South Korean fermentation biotech company founded in 2000 that develops and sells proprietary microbial feed additives, animal pharmaceuticals (via Daonechem), and functional ingredients (via US subsidiary Nutraferma) to livestock producers and animal nutrition companies across 15+ countries.
- Ownership category
- akta.pro rank
Gene BioTech industry classification
Industry- Product category
- Animal Feed Additives
- NAICS
- Other Animal Food Manufacturing (311119), Animal Food Manufacturing (31111)
- SIC
- Food And Kindred Products (2000)
- akta.pro industry
- Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support)Amino Acid Premixes & ConcentratesAgriculture & Food Production/Animal Feed Manufacturing/Feed Premixes & Concentrates (Vitamins, Minerals, Additives)Phytogenics & Botanicals (Essential Oils, Plant Extracts)Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)Mycotoxin Risk Management (Binders, Deactivators)Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)Livestock & Poultry Nutrition (Feed & Premixes)Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals)
Keywords
Where Gene BioTech is headquartered
LocationHeadquarters
- HQ city
- Gongju
- HQ country
- South Korea
- HQ region
- Asia
Offices3 records
Markets served
Gene BioTech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Feed Additives Sales: Sale of proprietary fermentation-based feed additives including Artvill, PepSoyGen, Natufermen, Enervance, and D-L Methionine to livestock, poultry, aquaculture, and ruminant producers worldwide.
- Animal Pharmaceuticals: Through subsidiary Daonechem (established 1969), sales of veterinary medicines including livestock disease treatments, injectables, and vaccines to domestic and international markets.
- Nutraceutical Ingredients: Global supply of functional ingredients and raw materials developed in-house to various countries through US subsidiary Nutraferma Inc.
- R&D Services and Technology Licensing: Government-funded research projects and technology development partnerships with universities, including IPET projects and ministry-funded initiatives.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Gene BioTech product offering
Product offeringCore offering
Gene BioTech develops, manufactures, and sells fermentation-based animal feed additives (Artvill, PepSoyGen, Natufermen, Enervance, D-L Methionin) that improve livestock digestion, immunity, and feed conversion without antibiotics. Through subsidiary Daonechem it supplies veterinary pharmaceuticals (vaccines, injectables, disease treatments), and through US subsidiary Nutraferma Inc. it distributes functional feed ingredients globally with 10,000+ tons of annual production capacity.
Product overview
Gene BioTech (진바이오텍) is a fermentation-focused life sciences company that develops biological resources for animal husbandry, agriculture, food, and pharmaceutical applications using eco-friendly biotechnology. The company offers a portfolio of feed additive products including Artvill (natural plant extract), PepSoyGen (fermented soybean meal), Natufermen (multi-strain probiotics), Enervance, and D-L Methionin, serving pig, poultry, ruminant, aquaculture, goat, horse, and camel segments. The company operates through its subsidiary Daonechem (animal pharmaceuticals) and US-based Nutraferma for global market expansion.
Differentiator
Problem solved
Functional benefit
Brands
- Artvill: Natural plant extract additive for animals
- PepSoyGen
- Natufermen
- Enervance
- D-L Methionin
Products and services
- Artvill Natural plant extract additive for animal feed, particularly used for pigs, goats, horses, and camels.
- PepSoyGen Fermented soybean meal product used for animal nutrition across pigs, poultry, and other livestock.
- Natufermen Multi-strain probiotics for gut health, designed to improve digestion and animal well-being.
- Enervance Feed additive product for pigs designed to improve energy efficiency and animal performance.
- D-L Methionin Amino acid feed additive for pigs to support healthy growth and nutrition.
- Feed Additives (사료첨가제) Business Segment Business segment covering all feed additives developed using Korean traditional fermentation techniques, including functional feed ingredients that improve digestion, immunity, and nutrient uptake.
- Daonechem Animal Pharmaceuticals (동물용의약품)
- Nutraferma Functional Feed Ingredients US subsidiary of Gene BioTech with annual production capacity of 10,000+ tons, supplying functional additives and raw materials developed by Gene BioTech to global markets.
Quantifiable outcome
- Greenhouse gas reduction in ruminants through specialized feed additives
- +2 more outcomes
Companies that use Gene BioTech
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Gene BioTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Gene BioTech partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- Seoul National University (SNU)coreMultiple collaborative R&D projects including cultured meat production technology, microbiome research, and probiotic development. Joint research on pig intestinal microbes, livestock odor reduction, and functional feed additives.
- Dankook University (DKU)coreCollaborative projects on eco-friendly feed additives based on microbiome research, swine farm odor improvement using microbial genomic information, and various government-funded R&D initiatives.
- Kyungpook National University (KNU)coreJoint research on microbial utilization technology for swine robustness and productivity, ruminant total mixed ratio microbial inoculant development, and canine functional food development.
- IPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry)coreGovernment technology planning and evaluation institute providing funding for multiple R&D projects including dietary supplement development for pig digestive and respiratory microbiomes (2024-2028, 270 million KRW).
- Nutraferma Inc.coreUS subsidiary established in 2007 for global market expansion. Annual production capacity of 10,000+ tons. Distributes proprietary functional feed additives and raw materials worldwide.
- Daonechem Co., Ltd.coreAnimal pharmaceutical company established in 1969, exporting products to 15 countries. Produces livestock disease treatments, injectables, vaccines, vitamins, and natural antibiotic alternatives.
- Chungnam National University (CNU)coreCollaborative research on greenhouse gas mitigation technology in livestock and various fermentation technology projects.
- Sunchon National University (SCNU)coreJoint project on greenhouse gas mitigation technology development in livestock sector (2022-2025, 330 million KRW).
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Gene BioTech competitors and assessment
Company assessmentBroad incumbents
- dsm-firmenich: Global animal nutrition and health leader offering probiotics, vitamin premixes, mycotoxin binders, and feed additives for livestock, poultry, and aquaculture. Directly comparable to Gene BioTech's PepSoyGen, Natufermen, and D-L Methionin lines, but at vastly larger scale and geographic reach.
- Alltech: Global animal nutrition company with a strong fermentation-based technology platform producing prebiotics, probiotics, mycotoxin binders, and nutrigenomics solutions. Direct overlap with Gene BioTech's Natufermen probiotics, mycotoxin degraders, and immune-modulating feed additives.
- CJ CheilJedang BIO: Korean fermentation and bio-industrial giant with significant animal nutrition and amino acid (lysine, methionine, threonine) operations. Comparable fermentation technology base and overlapping product portfolio (amino acids, probiotics) with Gene BioTech.
- Elanco Animal Health: Global animal health company offering pharmaceuticals, vaccines, and nutritional health products for livestock and pets. Comparable to Daonechem's veterinary pharmaceutical line and provides a reference for the integrated animal health + nutrition value proposition.
- Adisseo: Specialist in animal nutrition additives (methionine, vitamins, enzymes, and specialty feed ingredients), recently acquired by China National Bluestar. Comparable in feed additive focus and global distribution to Gene BioTech's amino acid and specialty additive lines.
Emerging players
- Ohly (ABF Ingredients): Specialty ingredient producer of yeast-based and fermentation-derived products for animal nutrition and human food. Comparable fermentation technology and feed ingredient portfolio, focused on yeast extracts, beta-glucans, and protein ingredients.
Direct peers
- Phibro Animal Health: Global animal health and nutrition company offering nutritional specialty products, vaccines, and pharmaceuticals for livestock. Comparable mix of feed additives plus animal pharmaceuticals — same combined proposition Gene BioTech offers through its parent + Daonechem structure.
- Novonesis (formerly Chr. Hansen / Novozymes Bioactives): Merger of Chr. Hansen and Novozymes creating the world leader in microbial and fermentation-based solutions including probiotics, silage inoculants, and biosolutions for animal health. Closest direct peer to Gene BioTech's solid-state fermentation and microbial strain platform.
- Kemin Industries: Privately held global manufacturer of feed additives, animal nutrition ingredients, and health solutions including acidifiers, probiotics, and immune modulators for livestock and aquaculture. Direct overlap with Gene BioTech's multi-strain probiotic and gut health portfolio.
- Easy Bio Inc. Korean KOSDAQ-listed feed additive specialist producing probiotics, enzyme preparations, and functional feed ingredients for livestock and aquaculture. Closest Korean-headquartered peer competing in the same domestic and export markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights6 records
Customer concentration
Gene BioTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gene BioTech leadership team
Management profileNumber of profiles
Profiles1 record
Gene BioTech subsidiaries and ownership
Company hierarchySubsidiaries2 records
Gene BioTech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gene BioTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gene BioTech
What does Gene BioTech do?
Gene BioTech develops, manufactures, and sells fermentation-based animal feed additives (Artvill, PepSoyGen, Natufermen, Enervance, D-L Methionin) that improve livestock digestion, immunity, and feed conversion without antibiotics. Through subsidiary Daonechem it supplies veterinary pharmaceuticals (vaccines, injectables, disease treatments), and through US subsidiary Nutraferma Inc. it distributes functional feed ingredients globally with 10,000+ tons of annual production capacity.
Is Gene BioTech a public or private company?
Gene BioTech is a public company. It is classified as public and is currently operating.
When was Gene BioTech founded?
Gene BioTech was founded in 2000. It employs 11 to 50 people.
Where is Gene BioTech based?
Gene BioTech is headquartered in Gongju, South Korea, in the Asia region.
How does Gene BioTech make money?
Four revenue lines are on record. Feed Additives Sales are the primary driver. The others are animal Pharmaceuticals, nutraceutical Ingredients and R&D Services and Technology Licensing.
Who are Gene BioTech's main competitors?
Broad incumbents on record are dsm-firmenich, Alltech, CJ CheilJedang BIO, Elanco Animal Health and Adisseo. Ohly (ABF Ingredients) is listed as an emerging player. Direct peers are Phibro Animal Health, Novonesis (formerly Chr. Hansen / Novozymes Bioactives), Kemin Industries and Easy Bio Inc..
Does Gene BioTech have an API?
No public API is recorded for Gene BioTech.
What industry is Gene BioTech in?
Gene BioTech's product category is Animal Feed Additives. Its primary akta.pro industry code is AFADALAO, Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support), with a secondary code of AFADAGAE, Amino Acid Premixes & Concentrates. Its NAICS code is 311119 and its SIC code is 2000.